Cassini Listed as “Best Technology 2014” by Cataract & Refractive Surgery Today’s editorial board

Cassini receives second confirmation of being one of the best technological innovations within ophthalmology.

Jan 22, 2015

The Hague, the Netherlands (January 21, 2015) – In Cataract & Refractive Surgery Today’s (CRST) annual article, members of the editorial board share their selection of best innovations of 2014. In the 2014 edition of “Best Technology 2014”, Cassini has been listed by Dr. Jackson, founder and director of Jacksoneye in Lake Villa, Illinois and Dr. Packer, ophthalmologist and president of Mark Packer Consulting.

Both ophthalmologists believe Cassini’s biggest impact will come from improving outcomes based on Cassini’s Total Corneal Astigmatism (TCA) information. Cassini Total Corneal Astigmatism provides cataract refractive surgeons important information on both anterior as well as posterior corneal astigmatism, allowing for highly accurate correction of corneal astigmatism. Correcting astigmatism is important for achieving superior outcomes for more than 50% of all patients. Conventional cataract protocols typically take into account astigmatism on the anterior surface of the cornea only.

The distinction of being listed in the “Best Technology 2014” issue of Cataract & Refractive Surgery Today is a confirmation of the great market penetration of Cassini in 2014 and a confirmation of another recent recognition awarded by The Ophthalmologist magazine in which Cassini was ranked #2 position of “Best Innovation 2014”.

Previous clinical studies have demonstrated that posterior corneal astigmatism could be a factor in generating unexpected postoperative outcomes.1 Research has shown that selecting toric IOLs based on anterior corneal measurements could lead to over-correction in eyes that have with-the-rule astigmatism (vertical steep axis) and under-correction in eyes that have against-the-rule astigmatism (horizontal steep axis). In addition, there seems to be a large variety in the relationship between anterior and posterior astigmatism in pre-cataract populations of patients.

“Treating Total Corneal Astigmatism as opposed to anterior astigmatism only will help achieve better refractive outcomes for cataract patients. In addition, the ability to analyze the Total Corneal Astigmatism properties pre-operatively will prove to be an important element in selecting the appropriate patients for premium cataract surgery and will therefore help to reduce refractive surprises and dissatisfied patients.” Says Jeroen Cammeraat, CEO at i-Optics.

About i-Optics

i-Optics pioneers smart and superior eye diagnosis solutions that are affordable, fast and user-friendly for care providers worldwide to serve their patients best. Its innovations include:

  • EasyScan – A breakthrough, zero-dilation retinal imaging system that uses SLO technology to diagnose retinal diseases including diabetic retinopathy, age-related macular degeneration (AMD) and glaucoma.
  • EasyScan three minute eye care test – A full service program for opticians to differentiate their dispensary. The program creates a unique consumer experience that allows the optician to differentiate from competition and boost revenues.
  • EyePrevent – An effective and cost-efficient retinal disease screening service for diabetic and other patients to help prevent vision loss.
  • Cassini – A first-of-its-kind Corneal Shape Analyzer based on Color LED Technology. Cassini measures the axis and magnitude of corneal astigmatism and is important for premium IOL planning. Cassini completes the premium cataract-refractive platform.


For more information please contact Jeroen Cammeraat, CEO +31 70 399 31 12 or

Find out why top surgeons choose Cassini

Please click here to receive the Cassini information package.

Read the full article here.

article references

1. Koch DD, Ali SF, Weikert MP, Shirayama M, Jenkins R, Wang L. Contribution of posterior corneal astigmatism to total corneal astigmatism. J Cataract Refract Surg. 2012 Dec;38(12):2080-7.

Cassini receives second confirmation of being one of the best technological innovations within ophthalmology.